For 25 years, FRT-Fondation René Touraine has been at the service of dermatology
developing actions to support therapeutic progress in dermatology.

More than ever we need your help.

   Make a donation now!

 You are visiting a Fondation René Touraine website.    Donate English Français

Home > Fondation René Touraine > Who we are >

Transparency statement

Read our transparency statement.

FONDATION RENE TOURAINE’S (FRT) TRANSPARENCY STATEMENT

Policy on Financial Support by Commercial Companies

FRT is officially recognised for its public utility. According to French law, the statute of «public utility» for a Foundation implies that there are no relations of subordination between the Foundation and the companies that contributed to the initial endowment of the Foundation.

The Foundation is steered by a Board of Directors, advised by a Scientific Board constituted of European leading professors of dermatology.

FRT supports the improvement of quality access to skin care through actions gathering dermatologists, researchers, pharmaceutical and cosmetic industries, health authorities and patient associations. FRT aims thus to connect people in order to improve health care access and quality. Because FRT aims to connect all these instigators of therapeutic progress, it is therefore bound to attract the attention of companies which are particularly willing to commit in fostering the development of clinical and therapeutic research in dermatology.

The main actions of the Foundation include:

  • research fellowships,
  • an annual high-level symposium on a different skin cell,
  • a prestigious lecture at ESDR (European Society of Dermatological Research) and at EADV (European Academy of Dermatology and Venereology),
  • a reference book on the management of skin diseases available for free on the web,
  • the development and management of international networks focusing on improving access to quality skin care, such as the "Genodermatoses & Rare Skin Disorders Network" and the "SPIN - Skin Inflammation & Psoriasis International Network".

FRT funding allocated for operating costs comes from different resources, none of them incurring a conflict of interest. A 1,5 million € endowment was gathered by 11 companies 25 years ago, enabling the creation of FRT. Two representatives of these companies (one for the pharmaceutical companies and one for the cosmetic companies) have a seat at the Board of Directors and can make proposals regarding the the different activities of the Foundation. However, these proposals are submitted to the collegial approval of the Boards of Directors with no tangible counterparts established.

The core activities of FRT are thus funded by the income generated by the endowment, as well as by grants of other private sector and non-profit organisations. Pharmaceutical and cosmetic companies are indeed solicited for contribution for punctual activities.

  • The commented bibliography published every year for the scientific meeting organised by FRT on a different skin cell function is sponsored in equal share by the majority of the companies having contributed to the initial endowment. These companies are also asked for sponsoring in exchange for an acknowledgement in all communication materials related to the scientific meeting.
  • The triennial congress organised by SPIN generates a relevant income to the functioning expenses of the network, namely through registration fees and congress sponsorship. Other expenses of this action, such as the organisation of symposia and research projects, are sometimes supported by unrestricted grants from the private sector as well by institutional grants (e.g. grant from the EADV - European Academy of Dermatology and Venereology for 2017-2018).
  • Certain operational expenses of the "Genodermatoses & Rare Skin Disorders Network" (salaries and work meetings) are also supported by grants either from the private sector of from other non-profit organisations, such as the EADV for the period 2014-2016, or even by public institutions such as the European Commission for the period 2008-2011 and from 2017 onwards via the APHP (Parisian Hospitals Administration).

With regards to industry grants, besides associating the logo of the partner industry and acknowledging their contribution to the different projects and activities, no merchant counterparts are involved.

Grants given by commercial companies which are allocated to cover operational costs (salaries, stationary, communications and website maintenance) and are inscribed in a more global partnership, where the grant aims to support the development of cooperation networks, training activities, clinical and therapeutic research and improvement of skin care management.

Every year, the latest financial report is published on FRT’s website.
To see these financial reports, click here.

This website uses cookies and Google Analytics to analyse the audience and improve its content. For more information about confidentiality rules related to the use of Google Analytics, click here: https://support.google.com/analytics/answer/6004245?hl=fr

Fondation René Touraine